Stefan Glombitza
Chief Executive Officer bei FORMYCON AG
Profil
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Aktive Positionen von Stefan Glombitza
Unternehmen | Position | Beginn |
---|---|---|
FORMYCON AG | Chief Executive Officer | 01.07.2022 |
Ehemalige bekannte Positionen von Stefan Glombitza
Unternehmen | Position | Ende |
---|---|---|
Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | - |
Ausbildung von Stefan Glombitza
University of Regensburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FORMYCON AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Hexal Pharmaforschung GmbH |